CAPTRUST Financial Advisors
BBIO icon

CAPTRUST Financial Advisors’s BridgeBio Pharma BBIO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$380K Buy
5,118
+1,404
+38% +$102K ﹤0.01% 2225
2025
Q4 		$284K Buy
+3,714
New +$244K ﹤0.01% 2289
2024
Q1 		– Sell
-25,997
Closed -$1.05M – 2192
2023
Q4 		$1.05M Sell
25,997
-4,273
-14% -$128K ﹤0.01% 1234
2023
Q3 		$798K Buy
30,270
+10,845
+56% +$308K ﹤0.01% 1334
2023
Q2 		$334K Buy
+19,425
New +$292K ﹤0.01% 1890
2022
Q3 		– Sell
-1,034
Closed -$9K – 2252
2022
Q2 		$9K Sell
1,034
-100
-9% -$836 ﹤0.01% 3788
2022
Q1 		$12K Buy
1,134
+573
+102% +$5.88K ﹤0.01% 3694
2021
Q4 		$9K Buy
561
+114
+26% +$4.82K ﹤0.01% 3763
2021
Q3 		$21K Buy
447
+268
+150% +$14.4K ﹤0.01% 3120
2021
Q2 		$11K Sell
179
-25
-12% -$1.43K ﹤0.01% 3483
2021
Q1 		$13K Buy
+204
New +$13.3K ﹤0.01% 3273

Other funds holding BBIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
ACM
Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return